NCT07355894 Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) Status NOT_YET_RECRUITING Phase NA
NCT07313852 A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07313761 A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07310563 A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity Status COMPLETED Phase PHASE1
NCT07301424 Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL Status NOT_YET_RECRUITING Phase PHASE2
NCT07297979 Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) Status RECRUITING Phase PHASE1
NCT07293260 Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial Status RECRUITING Phase PHASE3
NCT07283640 A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE1
NCT07243470 Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07229157 Effect of Maridebart Cafraglutide on the Heart's Electrical Activity Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07226778 Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07226765 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy Status RECRUITING Phase PHASE3
NCT07225686 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy Status RECRUITING Phase PHASE3
NCT07223190 A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia Status NOT_YET_RECRUITING Phase PHASE3
NCT07222579 Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) Status RECRUITING Phase PHASE2
NCT07222553 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD Status NOT_YET_RECRUITING Phase PHASE2
NCT07213674 A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE3
NCT07203053 A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 Status RECRUITING Phase PHASE2
NCT07192237 Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE2
NCT07178912 Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Status NOT_YET_RECRUITING Phase PHASE2